1. Human iNPC therapy leads to improvement in functional neurologic outcomes in a pig ischemic stroke model.
- Author
-
Lau VW, Platt SR, Grace HE, Baker EW, and West FD
- Subjects
- Animals, Appetite physiology, Disease Models, Animal, Humans, Magnetic Resonance Imaging methods, Male, Neurologic Examination methods, Posture physiology, Reproducibility of Results, Swine, Treatment Outcome, Induced Pluripotent Stem Cells transplantation, Infarction, Middle Cerebral Artery diagnostic imaging, Infarction, Middle Cerebral Artery physiopathology, Infarction, Middle Cerebral Artery therapy, Outcome Assessment, Health Care methods, Recovery of Function physiology
- Abstract
Introduction: Stroke is the leading cause of disability in the United States but current therapies are limited with no regenerative potential. Previous translational failures have highlighted the need for large animal models of ischemic stroke and for improved assessments of functional outcomes. The aims of this study were first, to create a post-stroke functional outcome assessment scale in a porcine model of middle cerebral artery occlusion (MCAO) and second, to use this scale to determine the effect of human-induced-pluripotent-cell-derived neural progenitor cells (iNPCs) on functional outcome in this large animal stroke model., Materials and Methods: Eight 6-month-old Landrace mix pigs underwent permanent MCAO. Five days following MCAO, pigs received intraparenchymal injections of either iNPCs or PBS. A post-stroke assessment scale was developed to measure functional outcome. Evaluations were performed at least 1-3 days prior to MCAO and repeated 1 day, 3 days, and 5 days post-stroke as well as 1 day, 3 days, 1 week, 2 weeks, 4 weeks, 6 weeks, 9 weeks, and 12 weeks post-injection. Comparisons of scores between animals receiving iNPCs or PBS only were compared using a two-way ANOVA and a Tukey's post-hoc t test., Results: The developed scale was able to consistently determine differences between healthy and stroked pigs at all time points. iNPC-treated pigs showed a significantly faster recovery in their overall scores relative to PBS-only treated pigs with the parameters of appetite and body posture exhibiting the most improvement in the iNPC-treated group., Conclusions: We developed a robust and repeatable functional assessment tool that can reliably detect stroke and recovery, while also showing for the first time that iNPC therapy leads to functional recovery in a translational pig ischemic stroke model. These promising results suggest that iNPCs may 1 day serve as a first in class cell therapeutic for ischemic stroke.
- Published
- 2018
- Full Text
- View/download PDF